Home

Semler Scientific, Inc. - Common Stock (SMLR)

32.05
-2.01 (-5.89%)
NASDAQ · Last Trade: Apr 4th, 10:46 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Semler Scientific, Inc. - Common Stock (SMLR)

Abbott Laboratories ABT -1.56%

Abbott Laboratories is a major global healthcare company known for its extensive range of products, including diagnostics and devices for chronic diseases. They compete with Semler Scientific in the diagnostics arena, offering a variety of innovative health technologies. Abbott has a significant competitive advantage due to their established brand presence, extensive R&D capabilities, and broad regulatory approvals across multiple markets, often allowing them to lead in product adoption among healthcare providers.

Cardinal Health, Inc. CAH -2.13%

Cardinal Health is a large player in the healthcare supply chain and pharmaceutical distribution market, providing products and services that sometimes include diagnostic technologies. While their scope is broader than Semler Scientific, which focuses specifically on diagnostic capabilities for chronic disease management, competition arises in their overlapping interest in improving managed care services and patient outcomes. Cardinal Health has a significant advantage in resources and distribution channels, making them a formidable competitor, especially when it comes to large healthcare systems.

DarioHealth Corp. DRIO -0.10%

DarioHealth Corp. operates in the digital health space, providing an integrated platform for managing chronic conditions like diabetes. They compete with Semler Scientific by focusing on user-friendly technology that combines monitoring with real-time data analytics. Dario's emphasis on personalized health solutions and integration with mobile devices offers a robust alternative to Semler's diagnostic tools, but Semler's specialization in clinical diagnostics may provide it with a more established foothold in certain healthcare settings.

Dexcom, Inc. DXCM -6.12%

Dexcom specializes in continuous glucose monitoring systems, which directly compete with Semler Scientific's diagnostics for diabetes management. Both companies are focused on improving patient outcomes through technology, but Dexcom's deep integration with consumer devices and robust data-sharing capabilities position it as a leader in real-time monitoring. Their advanced technology and established market presence provide a significant competitive advantage over Semler Scientific, which may not have the same level of consumer engagement.

Propeller Health

Propeller Health focuses on digital therapeutics for chronic respiratory diseases, offering connected inhalers that track medication usage and provide adherence data. This directly competes with Semler Scientific's offerings, which aim to optimize chronic disease management through innovative diagnostic solutions. While both companies target the chronic disease market, Propeller leverages advanced digital health technology and mobile applications to engage patients directly, giving them a competitive edge in patient-centric solutions.